YK-11 Solubility & Diluents — Research Reference

Achieving optimal solubility and preparing stable solutions of YK-11 is paramount for ensuring the integrity and reproducibility of experimental results in preclinical and mechanistic research. As a steroidal compound studied for its modulatory effects on androgen receptors and myostatin pathways, the precise formulation of YK-11 solutions directly impacts its bioavailability in research systems, influencing subsequent cellular and molecular observations. This comprehensive reference is designed to guide researchers in cellular aging and related fields through the intricacies of YK-11 solubility, diluent selection, and solution preparation for rigorous laboratory investigations.

YK-11 has garnered significant attention within the research community, evidenced by numerous publications indexed in PubMed and several registered studies on ClinicalTrials.gov, highlighting its relevance in exploring novel mechanisms related to muscle tissue dynamics and anabolic signaling pathways. Understanding its physicochemical properties, particularly solubility, is not merely a technical detail but a foundational requirement for reliable scientific inquiry. This document provides detailed considerations for preparing YK-11 solutions, emphasizing methods to ensure stability, mitigate degradation, and verify solution integrity for a broad spectrum of research applications.

The Research Context of YK-11: A Steroidal Modulator

YK-11 stands as a compelling subject within the landscape of cellular aging and related research, primarily characterized by its unique dual classification as a selective androgen receptor modulator (SARM) and a potential myostatin modulator. Its molecular structure, featuring a steroidal backbone, informs many of its physicochemical properties and biological interactions, positioning it distinctively among compounds investigated for their effects on muscle anabolism and bone mineral density in various research models. The scientific community’s interest in YK-11 is underscored by its presence in numerous PubMed-indexed publications, reflecting extensive exploration into its mechanisms and potential applications in understanding muscle wasting conditions and bone degradation processes. Furthermore, its progression to several registered studies on ClinicalTrials.gov indicates a broader recognition of its significance as a research tool for delineating complex biological pathways.

Research into YK-11’s mechanism of action primarily focuses on its interaction with androgen receptors (AR) and its putative role in myostatin pathway modulation. While many SARMs exhibit tissue-selective AR agonism, YK-11’s unique steroidal framework and reported ability to potentially inhibit myostatin, a potent negative regulator of muscle growth, present a multifaceted research avenue. In cellular and animal models, investigators explore how YK-11 influences myogenesis, osteogenesis, and the intricate signaling cascades that govern these processes. The objective is often to understand the molecular underpinnings of sarcopenia, cachexia, and osteoporosis, conditions frequently associated with aging and various pathologies. Understanding these mechanisms at a fundamental level allows researchers to probe potential targets for therapeutic intervention, though it must be rigorously maintained that YK-11 itself is strictly for research use and not for human consumption.

For researchers engaged in dissecting the complexities of cellular aging and tissue homeostasis, YK-11 offers a valuable probe. Its ability to potentially enhance lean muscle mass and improve bone density in preclinical models, as observed in various studies, positions it as a significant compound for investigating conditions like age-related muscle atrophy and skeletal fragility. The detailed study of its effects, from gene expression changes to protein synthesis rates, contributes to a growing body of knowledge regarding anabolic signaling pathways. This includes exploring its impact on satellite cell proliferation, differentiation, and the subsequent hypertrophy of muscle fibers, all critical aspects of maintaining physiological function throughout the lifespan. For more detailed insights into its specific research applications, please refer to our dedicated resource on YK-11 research.

The steroidal nature of YK-11 necessitates careful consideration in its handling and experimental design. Its structural resemblance to natural steroids, while conferring certain biological activities, also dictates its solubility characteristics and metabolic fate in research systems. Investigators must account for potential interactions with steroid-binding proteins and metabolic enzymes in their chosen models, which can significantly influence the compound’s effective concentration and duration of action. The ongoing research efforts aim not only to elucidate YK-11’s direct effects but also to understand the broader implications of steroidal modulation within complex biological systems, contributing to a more comprehensive understanding of endocrine regulation and its role in health and disease. Further exploration into its specific mechanism of action can be found at YK-11 Mechanism of Action.

Fundamental Principles Governing Compound Solubility in Research

The accurate and reproducible preparation of research solutions hinges critically on a thorough understanding of a compound’s solubility. Solubility, defined as the maximum concentration of a solute that can dissolve in a solvent at a given temperature and pressure to form a stable solution, is a thermodynamic property influenced by a multitude of factors. At its core, solubility is governed by the interplay of intermolecular forces: the attractive forces between solute molecules (solute-solute interactions), between solvent molecules (solvent-solvent interactions), and between solute and solvent molecules (solute-solvent interactions). For a compound to dissolve, the energy gained from solute-solvent interactions must sufficiently overcome the energy required to break solute-solute and solvent-solvent interactions. This principle, often summarized by “like dissolves like,” emphasizes the importance of matching the polarity and hydrogen bonding capabilities of the solute with those of the solvent.

Key physicochemical properties that dictate a compound’s intrinsic solubility include its molecular structure, functional groups, molecular weight, crystallinity, and melting point. Polar compounds, characterized by functional groups capable of hydrogen bonding (e.g., hydroxyl, amine, carboxyl), tend to dissolve well in polar solvents like water or ethanol. Conversely, non-polar, lipophilic compounds, often rich in hydrocarbon chains or aromatic rings, exhibit high solubility in non-polar organic solvents such as hexane or toluene. Steroidal compounds, like YK-11, typically possess a significant lipophilic character due to their polycyclic hydrocarbon backbone, which often results in poor aqueous solubility but good solubility in organic solvents. Furthermore, the presence of ionizable groups and the compound’s pKa (acid dissociation constant) are crucial, as solubility can be highly pH-dependent. Adjusting the pH to ionize a weakly acidic or basic compound often dramatically increases its aqueous solubility, a principle widely exploited in pharmaceutical formulations and research preparations.

Factors Influencing Observed Solubility

• Temperature: For most solids, solubility increases with increasing temperature, as higher kinetic energy facilitates the breaking of crystal lattice forces and promotes solute-solvent interactions. However, some exceptions exist.
• Pressure: While less significant for solid solutes in liquid solvents, pressure can affect the solubility of gases and, to a lesser extent, impact the density and thus the “effective” concentration of solutes in highly compressible systems.
• Crystal Form/Polymorphism: Different crystalline forms (polymorphs) of the same compound can exhibit varying solubilities due to differences in their crystal lattice energy. Amorphous forms often possess higher solubility than their crystalline counterparts.
• Common-Ion Effect: The solubility of a sparingly soluble salt can be decreased by the addition of a soluble salt containing a common ion.
• Salting Out/In: High concentrations of electrolytes can decrease (salting out) or, less commonly, increase (salting in) the solubility of organic compounds in aqueous solutions by affecting solvent structure or forming complexes.

Beyond these intrinsic and extrinsic factors, the practical aspect of solubility in research involves distinguishing between thermodynamic and kinetic solubility. Thermodynamic solubility represents the true equilibrium solubility, where no more solute can dissolve at a given temperature, regardless of time. Kinetic solubility, often measured quickly, may represent supersaturated solutions that are metastable and can precipitate over time. For robust and reliable research, achieving thermodynamic solubility is generally preferred, although kinetic solubility can be relevant in certain rapid screening assays. The meticulous selection of solvents, careful control of environmental conditions, and appropriate mixing techniques are paramount to ensure the preparation of stable, homogenous solutions that accurately reflect the intended concentration, thereby preventing experimental variability and misinterpretation of results. A fundamental understanding of these principles underpins all subsequent decisions regarding diluents, preparation protocols, and stability assessments for compounds like YK-11.

Intrinsic Solubility Characteristics of YK-11 for Laboratory Use

The intrinsic solubility profile of YK-11 is largely dictated by its distinct chemical structure: a steroidal compound with a notable degree of lipophilicity. This molecular architecture, comprising several fused rings and specific functional groups, imparts characteristics that typically lead to poor aqueous solubility. Steroidal compounds, due to their extensive non-polar hydrocarbon regions, tend to interact weakly with the highly polar water molecules, making it energetically unfavorable to disrupt the strong hydrogen-bonding network of water and the crystal lattice of the compound. Consequently, researchers anticipate and typically observe that YK-11 exhibits low solubility in purely aqueous media, such as physiological buffers or cell culture media, necessitating the use of co-solvents or alternative solubilization strategies for most research applications.

Conversely, the lipophilic nature of YK-11 suggests that it will readily dissolve in a variety of organic solvents. Solvents that match its polarity and can form favorable intermolecular interactions with its non-polar regions are ideal candidates for preparing concentrated stock solutions. Common organic solvents such as dimethyl sulfoxide (DMSO), ethanol (EtOH), and dimethylformamide (DMF) are typically effective at dissolving YK-11 to form clear, stable stock solutions at high concentrations (e.g., millimolar range). The choice among these organic solvents often depends on downstream assay compatibility, cell line tolerance (for in vitro studies), and toxicological considerations for in vivo models. Acetone and acetonitrile may also serve as effective solvents, particularly for analytical sample preparation, though their utility in biological systems can be more restricted due to volatility and potential cellular toxicity.

Factors Affecting YK-11’s Intrinsic Solubility

• Chemical Structure: The specific arrangement of functional groups and the steroidal ring system contribute to its overall polarity and hydrogen bonding capacity. While there might be some polar groups, the predominant lipophilic backbone governs its general solubility.
• Molecular Weight: While not excessively high, YK-11’s molecular weight contributes to the size and complexity of its crystalline lattice, requiring significant energy input for dissolution.
• Crystallinity and Polymorphism: As a synthesized compound, YK-11 can exist in various crystalline forms (polymorphs) or as an amorphous solid. Differences in crystal packing can lead to variations in lattice energy and, consequently, in intrinsic solubility. Researchers should ideally work with well-characterized material, and a Certificate of Analysis (COA) is crucial for confirming the purity and form of the compound, as impurities can also significantly impact solubility and stability.
• Purity: High-purity YK-11, as supplied for research, is essential. Impurities can act as nucleation sites, promote precipitation, or alter the solvent’s properties, leading to misleading solubility data.

For applications requiring aqueous solutions, such as cell culture experiments or injection vehicles for animal studies, YK-11’s poor intrinsic aqueous solubility necessitates strategic approaches. Direct dissolution in water or buffer will typically result in a suspension or very low concentration solution, which may not be biologically relevant or stable. Instead, researchers often employ strategies like dissolving YK-11 initially in a small volume of a highly compatible organic solvent (e.g., DMSO or ethanol) and then diluting this stock solution into the aqueous medium. This method, known as co-solvency, relies on the organic solvent acting as a bridge to maintain YK-11 in solution at lower concentrations, provided the final concentration of the organic co-solvent is below cytotoxic or interfering levels. Other advanced techniques, such as the use of surfactants or cyclodextrins, may also be explored to enhance pseudo-aqueous solubility by forming micelles or inclusion complexes, respectively, to maintain YK-11 in a dispersed, soluble form suitable for various research paradigms.

Common Diluents and Solvents for YK-11 Research Preparations

The successful execution of YK-11 research critically depends on the judicious selection of appropriate diluents and solvents for preparing stable, homogeneous solutions. Given YK-11’s steroidal and lipophilic nature, its solubility profile dictates a preference for organic solvents for initial stock solution preparation, followed by strategic dilution into aqueous media where necessary. The choice of solvent or diluent is not trivial; it must be carefully weighed against factors such as compatibility with the research model (e.g., cell viability, enzymatic activity, animal health), assay interference, and the desired final concentration and stability of YK-11. Researchers must always ensure that the selected solvent system does not introduce confounding variables or adverse effects that could compromise the integrity of their experimental results.

Primary Organic Solvents for Stock Solutions

• Dimethyl Sulfoxide (DMSO): A highly versatile aprotic solvent, DMSO is an excellent choice for dissolving lipophilic compounds like YK-11 to high concentrations. Its strengths include high dissolving power for a wide range of organic compounds and miscibility with water. However, DMSO can be cytotoxic at higher concentrations (typically above 0.1-0.5% v/v for most cell lines) and can affect cell membrane integrity or protein function. Its use in vivo is also limited by toxicity.
• Ethanol (EtOH): Absolute ethanol (200 proof) is another highly effective solvent for YK-11, offering good solubility. It is generally less cytotoxic than DMSO at comparable concentrations and is often preferred for in vitro applications where DMSO might be problematic. For in vivo use, smaller volumes of ethanol are tolerated, particularly for oral gavage or intraperitoneal injections when diluted.
• Dimethylformamide (DMF): Similar to DMSO in its polar aprotic nature and dissolving power, DMF is also a strong solvent for YK-11. However, DMF is generally considered more toxic than DMSO and ethanol, especially for cell culture and in vivo applications, limiting its use primarily to analytical sample preparation or situations where lower concentrations can be achieved without toxicity.
• Acetonitrile (ACN): Primarily used for analytical purposes (e.g., HPLC), acetonitrile can dissolve YK-11. Its volatility and potential for cellular toxicity generally preclude its use as a primary solvent for biological research, except for initial stock preparation in non-aqueous contexts or when highly diluted.

When transitioning from concentrated organic stock solutions to aqueous media for biological experiments, careful dilution strategies are essential. For in vitro cell culture, a common approach involves dissolving YK-11 in a minimal volume of DMSO or ethanol to create a concentrated stock (e.g., 10 mM or 100 mM), and then diluting this stock extensively into cell culture medium. The goal is to achieve the desired experimental concentration of YK-11 while ensuring the final concentration of the organic co-solvent is below a critical threshold (typically <0.1% for DMSO) to avoid solvent-related toxicity or artifacts. Slow addition of the organic stock solution to vigorously stirred aqueous media can aid in maintaining solubility and preventing precipitation. Filtration through a 0.22 µm syringe filter for sterile applications is also critical for cell culture media.

For in vivo research, the choice of diluent becomes even more critical due to systemic exposure and potential for adverse effects. While organic co-solvents can be used at very low concentrations, often specialized vehicles are employed to maintain solubility and ensure bioavailability. These can include:

Diluent Type	Examples	Primary Use/Benefit	Considerations
Co-solvent Systems	DMSO/PEG400, Ethanol/Saline	Maintains solubility for lipophilic compounds	Toxicity of co-solvents, volume limits, compatibility with animal models
Surfactants/Emulsifiers	Polysorbate 80 (Tween 80), Cremophor EL	Forms micelles to solubilize hydrophobic compounds in aqueous media	Can cause irritation or alter drug disposition; potential for interaction with biological systems
Cyclodextrins	Hydroxypropyl-beta-cyclodextrin (HPβCD)	Forms inclusion complexes to enhance aqueous solubility	Relatively low toxicity, but specific cyclodextrin type and concentration must be optimized for each compound
Oil-based Vehicles	Sesame oil, Corn oil, MCT oil	For highly lipophilic compounds when oral gavage or IM injection is required	High viscosity, potential for depot formation, absorption variability

Researchers must carefully evaluate the characteristics of these vehicles, optimizing the ratio of co-solvents or excipients to achieve a stable, homogenous YK-11 solution that is well-tolerated by the experimental subjects and does not interfere with the biological outcomes being measured. Pilot studies to assess vehicle toxicity and stability are often warranted. Regardless of the chosen solvent, always handle YK-11 and its solutions in a well-ventilated area, preferably under a fume hood, and use appropriate personal protective equipment (PPE).

Detailed Protocols for YK-11 Solution Preparation and Dilution

Precision in solution preparation is paramount for reliable and reproducible research involving compounds like YK-11. This section outlines detailed protocols for preparing YK-11 solutions, emphasizing accuracy, sterility, and stability. Given YK-11’s intrinsic lipophilicity, the strategy typically involves preparing a concentrated stock solution in an organic solvent, followed by careful dilution into an appropriate aqueous medium for experimental applications. All procedures should be performed under strict adherence to laboratory safety guidelines, including the use of personal protective equipment (PPE) such as gloves, eye protection, and working within a certified chemical fume hood.

Preparation of a Primary Stock Solution (e.g., in DMSO or Ethanol)

The first step involves creating a highly concentrated stock solution in a suitable organic solvent. DMSO and absolute ethanol are the most common choices due to their solvency power and relative compatibility with subsequent biological dilutions.

1. Determine Target Concentration: Decide on a practical stock concentration, typically in the millimolar (mM) range (e.g., 10 mM, 25 mM, 100 mM). Higher concentrations allow for smaller volumes of organic solvent in subsequent dilutions, minimizing solvent-induced cytotoxicity.
2. Calculate Mass of YK-11 Required: Using the molecular weight (MW) of YK-11 (e.g., assume 336.44 g/mol for illustrative purposes – *users must verify actual MW from COA*), calculate the mass needed.
   
   Formula: Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
   
   Example: For 10 mL of a 10 mM (0.01 mol/L) stock solution with MW = 336.44 g/mol:
   
   Mass = 0.01 mol/L × 0.01 L × 336.44 g/mol = 0.033644 g = 33.64 mg
3. Accurately Weigh YK-11: Using an analytical balance calibrated to at least four decimal places (e.g., 0.0001 g precision), carefully weigh the calculated mass of YK-11 powder into a sterile, appropriately sized glass vial or tube. Static electricity can affect weighing; an anti-static brush or ionizer may be helpful.
4. Add Organic Solvent: Add the precise volume of chosen organic solvent (e.g., DMSO or absolute ethanol) to the vial containing the YK-11 powder. Ensure the solvent is of high purity (e.g., cell culture grade DMSO, molecular biology grade ethanol).
5. Dissolve the Compound: Cap the vial tightly and mix thoroughly. This can be achieved by vigorous vortexing for several minutes. For stubborn dissolution, brief sonication in a water bath (e.g., 5-10 minutes) can be employed, taking care to avoid overheating. Ensure the solution is completely clear with no visible particulate matter.
6. Aliquot and Store: Once dissolved, aliquot the stock solution into smaller, pre-labeled cryovials or amber glass vials. This minimizes freeze-thaw cycles and reduces degradation over time. Store aliquots at -20°C or -80°C, protected from light.

Preparation of Working Solutions for Biological Assays

Working solutions are typically prepared by diluting the primary stock solution into an aqueous medium, such as cell culture medium, physiological saline, or assay buffer. This step requires careful consideration of the organic co-solvent concentration and sterility.

1. Determine Desired Final Concentration and Volume: Establish the YK-11 concentration required for your experiment and the total volume of working solution needed.
2. Calculate Volume of Stock Solution Required: Use the dilution formula C1V1 = C2V2.
   
   Example: To prepare 10 mL of a 1 µM YK-11 working solution from a 10 mM (10,000 µM) stock:
   
   V1 = (C2V2) / C1 = (1 µM × 10 mL) / 10,000 µM = 0.001 mL = 1 µL
   
   This indicates that 1 µL of the 10 mM stock solution is needed. Ensure accurate micropipetting for such small volumes.
3. Prepare Aqueous Diluent: Dispense the calculated volume of appropriate aqueous diluent (e.g., sterile cell culture medium, PBS, or saline) into a sterile container.
4. Gradual Addition and Mixing: Slowly add the calculated volume of the concentrated YK-11 stock solution to the aqueous diluent. During addition, gently swirl or vortex the aqueous diluent to ensure rapid mixing and prevent localized precipitation. This is crucial for maintaining solubility and homogeneity.
5. Filter Sterilization (for cell culture): If the working solution is for cell culture, perform filter sterilization using a 0.22
   

   Frequently Asked Questions

   What is the recommended primary solvent for dissolving YK-11 for research?

   For initial dissolution of YK-11 powder to create a concentrated stock solution, highly pure dimethyl sulfoxide (DMSO) or absolute ethanol are generally recommended due to YK-11’s steroidal and lipophilic nature, offering robust solvency.

   How can I improve the solubility of YK-11 if it precipitates in my experimental media?

   To prevent precipitation, ensure the primary stock solution is well-dissolved and filtered. When diluting into aqueous media, add the concentrated stock solution slowly with gentle mixing, and consider using a small percentage (typically <0.1-0.5%) of the organic solvent (e.g., DMSO or ethanol) as a co-solvent in the final aqueous medium to maintain solubility without inducing excessive cytotoxicity.

   What are common diluents for YK-11 stock solutions in cellular assays?

   For cellular assays, concentrated YK-11 stock solutions prepared in DMSO or ethanol are typically diluted into cell culture media (e.g., DMEM, RPMI) or buffered saline solutions such as phosphate-buffered saline (PBS). It is crucial to ensure the final concentration of the organic co-solvent in the cell culture is minimized to avoid cellular toxicity.

   How should YK-11 stock solutions be stored to maintain stability?

   YK-11 stock solutions should be aliquoted into small, amber glass vials or tubes, tightly sealed, and stored at -20°C or -80°C in the dark. Minimize freeze-thaw cycles by using single-use aliquots to preserve compound integrity and prevent degradation.

   What analytical methods are suitable for verifying YK-11 concentration in research solutions?

   High-Performance Liquid Chromatography (HPLC) with UV detection or Liquid Chromatography-Mass Spectrometry (LC-MS/MS) are the gold standards for accurately quantifying YK-11 concentration and assessing purity in research solutions. UV-Vis spectrophotometry can also be used for quick concentration estimates if YK-11 has a known molar extinction coefficient at a specific wavelength.

   Are there specific pH considerations for YK-11 solubility in aqueous solutions?

   As a steroidal compound, YK-11’s solubility is not typically highly sensitive to minor pH variations within physiological ranges (pH 6-8) as it lacks readily ionizable functional groups that would undergo significant protonation or deprotonation. However, extreme pH conditions (highly acidic or basic) can potentially induce degradation, so buffered neutral solutions are preferred.

   What are the best practices for handling YK-11 as a research chemical?

   When handling YK-11, researchers should always wear appropriate personal protective equipment (PPE), including laboratory coats, chemical-resistant gloves, and eye protection. All manipulations should be performed in a well-ventilated fume hood to minimize exposure. Proper labeling and waste disposal protocols must be strictly followed.

   Can YK-11 be dissolved in DMSO for long-term storage?

   Yes, YK-11 can be dissolved in DMSO for long-term storage as a stock solution. However, it is essential to use high-purity, anhydrous DMSO, aliquot the solution into small volumes, and store them frozen at -20°C or -80°C in the dark to prevent degradation and minimize the impact of freeze-thaw cycles.

   Scientific References

   • PubMed: YK-11
   • ClinicalTrials.gov: YK-11

   All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.